CLASS II Device recall · Reported 20 Jan 2021 · FDA Enforcement Report

AnshLabs - Sars-CoV2 IgM Elisa (u-Capture), Ivd recalled

Ansh Labs is recalling AnshLabs - Sars-CoV2 IgM Elisa (u-Capture), Ivd, distributed nationwide in the US. The recall was initiated on 18 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #/Expiration Date: 040720/2021-10-06, 041620/2021-10-15, 041720/2021-10-18, 042420/2021-10-15, 042720-A/2021-10-26
Quantity recalled327 kits (93 test per kit)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0842-2021
FDA event ID
87057
Recalling firm
Ansh Labs, Webster, TX
Classification
Class II
Status
Terminated
Recall initiated
18 Dec 2020
FDA classified
11 Jan 2021
Reported
20 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 Dec 2020Recall initiated by company
11 Jan 2021Classified by FDA+24 days
20 Jan 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the "limitation" section to include potential cross-reactivity with non-SARS-CoV2 strains.

Product as listed by the FDA

AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample DIL 1 x 100 mL, ENZ CONJ CONC 1 x 1.5 mL, Calibrators A-C 3 x 1.2 mL, CONJ DIL 1 X 12 mL, Stop SOLN 1 X 12 mL, TMB SOLN 1 X 12 mL, WASH CONC A 1 X 60 mL, (01)00853592008219 - Product Usage: intended for the qualitative detection of IgM antibodies in serum collected from the individuals suspected with signs and symptoms of COVID-19 infection by their healthcare provider.

Where it was distributed

US Nationwide distribution including in the states of TX, MO, OK, MD, FL, NY, OR, GA, NC. OUS: None

Nationwide FloridaGeorgiaMarylandMissouriNorth CarolinaNew YorkOklahomaOregonTexas

Questions about this recall

Why was it recalled?

Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the "limitation" section to include potential cross-reactivity with non-SARS-CoV2 strains.

Which lots are affected?

Lot #/Expiration Date: 040720/2021-10-06, 041620/2021-10-15, 041720/2021-10-18, 042420/2021-10-15, 042720-A/2021-10-26

Where was it sold?

US Nationwide distribution including in the states of TX, MO, OK, MD, FL, NY, OR, GA, NC. OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Test Kits & Diagnostics recalls

All 2,656